Safety and Efficacy of Tralokinumab in Older Adults With Moderate to Severe Atopic Dermatitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Safety and Efficacy of Tralokinumab in Older Adults With Moderate-to-Severe Atopic Dermatitis: A Secondary Analysis
JAMA Dermatol 2023 Aug 23;[EPub Ahead of Print], JF Merola, DC Butler, T Mark, S Schneider, Y Kim, K AbuabaraFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.